Cancer cell membrane-coated nanoparticles exploit homotypic targeting mechanisms mediated by surface adhesion molecules including N-cadherin, galectin-3, and epithelial cell adhesion molecule (EpCAM) [202]. Here, EPCAM is linked to cancer.